We are live on ! Find out more
ACM

AIGH Capital Management Portfolio holdings

AUM $1.59B
1-Year Est. Return 855.46%
This Fund
S&P 500
This Quarter Est. Return
+44.38%
1 Year Est. Return
+855.46%
3 Year Est. Return
+3,007.26%
5 Year Est. Return
+4,204.76%
10 Year Est. Return
AUM
$253M
AUM Growth
+$41.5M
Cap. Flow
-$8.84M
Cap. Flow %
-3.5%
Top 10 Hldgs %
58.67%
Holding
56
New
8
Increased
14
Reduced
10
Closed
17

Top Sells

Rank Stock Value
1
ANIP icon
ANI Pharmaceuticals
ANIP
+$15.8M
2
AVNW icon
Aviat Networks
AVNW
+$9.91M
3
MRAM icon
Everspin Technologies
MRAM
+$8.34M
4
BWEN icon
Broadwind
BWEN
+$3.17M
5
CLNN icon
Clene
CLNN
+$2.88M

Sector Composition

Rank Sector Weight
1 Healthcare 55.66%
2 Technology 27.01%
3 Industrials 17.27%
4 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SVREW
51
CALL
SaverOne 2014 Ltd Warrant
SVREW
-568,694
Closed -$79.2K
TPST icon
52
Tempest Therapeutics
TPST
$14.6M
-31,250
Closed -$125K
CAMP
53
DELISTED
CalAmp Corp.
CAMP
-131,180
Closed -$1.22M
OSA
54
DELISTED
ProSomnus, Inc. Common Stock
OSA
-378,528
Closed -$399K
MDNA
55
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
-4,339,983
Closed -$1.27M
CGRN
56
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
-1,800,000
Closed -$1.28M

Similar funds

AIGH Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, AIGH Capital Management held 56 positions worth $253M, up 20% from $211M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

AIGH Capital Management withdrew a net $8.84M in Q4 2023, closing 17 positions and reducing 10 holdings. Its most notable exit was ANI Pharmaceuticals, an estimated $15.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 56% of assets, up from 51% a quarter earlier, followed by Technology and Industrials.

Against the trend, AIGH Capital Management opened a new position in Profound Medical worth $5.49M.

  • AIGH Capital Management's largest Q4 2023 buy was Profound Medical: 646,733 shares worth $5.49M.
  • AIGH Capital Management added most to scPharmaceuticals in Q4 2023, an estimated $5.15M increase.
  • AIGH Capital Management's biggest Q4 2023 reduction was GSI Technology, cutting an estimated $2.65M.
  • AIGH Capital Management fully exited ANI Pharmaceuticals in Q4 2023, selling an estimated $15.8M.
  • AIGH Capital Management's ten largest holdings make up 59% of its $253M portfolio in Q4 2023.
  • AIGH Capital Management opened 8 new positions and closed 17 in Q4 2023.
  • AIGH Capital Management's portfolio value rose 20% quarter-over-quarter to $253M.

Based on AIGH Capital Management's 13F filing for Q4 2023, filed 12 Feb 2024.